Gene Therapy for Choroideremia

Scott Krzywonos, Thomas L. Edwards, MBBS, PhD (Cantab), FRANZCO

Show Description +

Tom L. Edwards, MBBS, PhD, FRANZCO, of the Nuffield Laboratory for Ophthalmology at the University of Oxford, England, reviews his research team's approach to using gene therapy to treat choroideremia. Dr. Edwards summaries the basics behind choroideremia, explains the unique challenges of viral vector delivery to the retina, and discusses a phase 1/2 trial employing a gene therapy strategy to deliver treatment to the back of the eye.

Posted: 9/19/2015

Up Next

Central Retinal Vein Occlusion in Young Patients

Francesco Boscia, MD, Scott Krzywonos

Giant Retinal Tears Case Series

Ogugua N. Okonkwo, MD, FRCS(Edin), FWACS, Scott Krzywonos

Complex Trauma Case

Manish Nagpal, MS, DO, FRCS (UK), Matteo Forlini, MD

Ultra-widefield Imaging in Normal Patients

Scott Krzywonos, Srinivas R. Sadda, MD

Preventing Vitreous Liquefaction

Nancy Holekamp, MD, Ranna Jaraha

27-gauge Surgery for VMT

Manish Nagpal, MS, DO, FRCS (UK), Matteo Forlini, MD

Micropulse Laser for Macular Disease

Sascha Fauser, MD, Scott Krzywonos

Suprachoroidal Surgical Approaches

Ehab N. El-Rayes, MD, PhD, Ranna Jaraha

Preview to the 2015 Retina Meeting in Nice

Anat Loewenstein, MD

Back to All Videos

Gene Therapy for Choroideremia

Scott Krzywonos, Thomas L. Edwards, MBBS, PhD (Cantab), FRANZCO

Posted: 9/19/2015

Please log in to leave a comment.

Comments

SRIMAT T MURALIDHAR

8 years ago

VERY INFORMATIVE. THOUGHT OF SHARING MY CASE SERIES IN A FAMILY WHERE MOTHER AND DAUGHTERS (AGE 23 ADN 32) THOUGHT ASYMPTOMATIC BUT SHOW SIGNS OF CHOROIDERIMIA AND THE MOTHER HAS TYPICAL ISLANDS ON Fundus AUTOFLORESCENCE. MY QUESTION IS ABOUT THE COST AND SOME MORE INFORMATION REGARDS TREATMENT AND ITS PROTOCOLS. THANKS

Meeting Coverage:

EURETINA Congress

Gene Therapy for Choroideremia

Up Next

Gene Therapy for Choroideremia

Comments

More From EURETINA: 2015 Coverage